FDA NDC Directory · JSON-LD · Markdown

DESVENLAFAXINE

NDC 68071-3790 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerNuCare Pharmaceuticals,Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA204028
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsDESVENLAFAXINE SUCCINATE (50 mg/1)
Marketing started20220131
Package count1

External sources

Source: openFDA. Public-domain (CC0).